<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03891342</url>
  </required_header>
  <id_info>
    <org_study_id>AZVCR 9307_1</org_study_id>
    <nct_id>NCT03891342</nct_id>
  </id_info>
  <brief_title>Effect of Fluid Challenge on Glycocalyx</brief_title>
  <official_title>Comparing of Two Regimes (Fast and Slow) of Fluid Challenge on Glycocalyx Assessed by Perfused Boundary Region in Septic and Elective Major Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Pilsen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Hradec Kralove</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional study comparing effect of two regimes of fluid challenge in patients with
      sepsis and in patients undergoing elective major surgery on glycocalyx by using perfused
      Boundary Region in sublingual microcirculation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effect of two regimes of fluid challenge on GCX in patients with sepsis and during elective
      surgery under general anesthesia.

      Hypothesis to be tested: Administration of 500 ml of balanced solution as a bolus impairs GCX
      more than prolonged administration.

      The aim of the study: Comparison of two regimes of fluid challenge in patients with sepsis
      and in patients undergoing elective major surgery.

      Type of the study: Open, randomized, interventional.

      Subjects:

      Part A: Patients with sepsis within 48 hours before admission to ICU requiring fluid
      challenge based on clinical or echocardiographic assessment.

      Part B: Patients during major elective surgery requiring fluid challenge based on clinical or
      echocardiographic assessment.

      Sample size calculation (based on expected difference in PRB, alpha error I =0,05 and study
      power = 0,99) = 52 patients. Investigators plan enrolment of 60 patients for each part,
      totally 120 patients.

      Intervention:

        -  500 ml of balanced crystalloid solution within 5 minutes (group &quot;fast&quot;)

        -  500 ml of balanced crystalloid solution within 30 minutes (group &quot;slow&quot;) Data to be
           recorded and analysed: Demographics, severity score, fluid response assessment,
           sublingual microcirculation by SDF imaging will be recorded at time points: baseline,
           after intervention, after 60 minutes, after 120 minutes, plasma syndecan-1 will be
           analysed before intervention and 120 minutes thereafter, microcirculatory data and
           Perfused Boundary Region.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">August 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of balanced crystalloid infusion time on endothelial glycocalyx</measure>
    <time_frame>baseline and at 20, 40, 60 and 120 minutes</time_frame>
    <description>Change in the endothelial glycocalyx thickness by PBR method</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Anesthesia</condition>
  <condition>Endothelial Dysfunction</condition>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Patients with sepsis/septic shock</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comaprison of fast or slow fluid bolus administration in patients with sepsis/septic shock 48hours before admission to ICU requiring fluid challenge as assessed by clinical examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Major surgical patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comaprison of fast or slow fluid bolus administration in patients undergoing major surgery requiring fluid challenge as assessed by clinical examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluid bolus administration</intervention_name>
    <description>Fluid bolus administration either &quot;fast&quot; in 5 minutes or &quot;slow&quot; in 30minutes.</description>
    <arm_group_label>Major surgical patients</arm_group_label>
    <arm_group_label>Patients with sepsis/septic shock</arm_group_label>
    <other_name>Fluid challenge</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        arm A: age over 18, diagnosis sepsis, fluid bolus administration indicated, arm B: age
        18-70, ASA status I-III, major surgery

        Exclusion Criteria:

        none.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Benes, Assoc.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charles University hospital in Plzen, Czech Republic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>FN Plzen</name>
      <address>
        <city>Plzen</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Hradec Kralove</investigator_affiliation>
    <investigator_full_name>Vladimir Cerny</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

